Skip to main content

Distinguished Speaker Series | Alexander Dizhoor, PhD

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Brunson Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

September 25, 2026 | Alexander Dizhoor, PhD

Regulation of retinal membrane guanylyl cyclase in photoreceptor function, congenital diseases and potential approaches to gene therapy 

 

Learn More About the Distinguished Speaker Series

Featured


Alexander Dizhoor, PhD
Alexander Dizhoor, PhD
  • Alexander Dizhoor, PhD, Hafter Chair Research Professor, Pennsylvania College of Optometry, Professor for the Department of Neurobiology and Anatomy, College of Medicine

Alexander M. Dizhoor, Ph.D., is a pioneering molecular biologist whose research has advanced the understanding of retinal signal transduction, congenital blindness, and gene therapy for inherited retinal diseases. He earned his Ph.D. in Molecular Biology from Moscow University and currently serves as the Hafter Chair in Pharmacology and Professor at the Pennsylvania College of Optometry at Salus at Drexel University. Throughout his career, including previous appointments at the University of Washington and Wayne State University, Dr. Dizhoor has made foundational contributions to the study of photoreceptor biology and the molecular mechanisms underlying retinal degeneration. His laboratory investigates the biochemical pathways that regulate vision and develops gene therapy approaches aimed at restoring sight and improving treatments for inherited forms of blindness.